NCT04283591

Brief Summary

Poststroke depression is seen with a frequency of up to 30%. Drug options for depression and accompanying sleep problems are limited; In addition, effective doses cannot be increased depending on the comorbidities of the patients and the side effect profiles and drug interactions of the drugs used. Acupuncture has been used in Chinese traditional medicine for more than 2000 years and there are findings that it has positive effects in post-stroke depression and anxiety disorders. The aim of this study is to examine the effectiveness and reliability of acupuncture treatment in depression and anxiety disorders developing after stroke and to reduce the need for multiple drugs and / or high-dose medication in the treatment of these complications. The hypothesis of the study: Acupuncture is an effective and reliable treatment method for depression and anxiety disorders in stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 22, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 25, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2020

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

February 9, 2021

Status Verified

February 1, 2021

Enrollment Period

1.3 years

First QC Date

February 22, 2020

Last Update Submit

February 6, 2021

Conditions

Keywords

strokeacupuncturedepressionanxiety

Outcome Measures

Primary Outcomes (2)

  • Hamilton Depression Rating Scale

    Assessed on 17 definitions, regarding the status of patient with a scale between 0 to 4.

    1 month

  • Hamilton Anxiety Rating Scale

    Assessed on 14 definitions, regarding the status of patient with a scale between 0 to 4.

    1 month

Secondary Outcomes (3)

  • Pittsburgh Sleep Quality Index

    1 month

  • Barthel Index

    1 month

  • Up-to-date Psychiatric Drug Use

    1 month

Study Arms (2)

Experimental Intervention

EXPERIMENTAL

Acupuncture Treatment Group: will get acupuncture treatment which will be applied to Baihui (DU20), Yintang (EX-HN3) points and bilateral Tai Chong (LR3), Hegu (LI4) points for 4 weeks, twice a week. They also will continue to receive the conventional rehabilitation programme.

Procedure: Acupuncture TreatmentOther: Conventional Rehabilitation Programme

No Intervention

OTHER

Control Group: will be included in the conventional rehabilitation programme and no interventional procedures will be made.

Other: Conventional Rehabilitation Programme

Interventions

Acupuncture Treatment Group will get acupuncture treatment which will be applied to Baihui (DU20), Yintang (EX-HN3) points of the hemiplegic side and bilateral Tai Chong (LR3), Hegu (LI4) points for 4 weeks, twice a week.

Experimental Intervention

They will continue to receive the conventional rehabilitation programme.

Experimental InterventionNo Intervention

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Minimum 2 months maximum 6 months after stroke
  • Volunteering for study
  • Mini-Mental State Examination \>17
  • Patients with Hamilton Depression Rating Scale\> 7 and/or Hamilton Anxiety Rating Scale\> 4 assessed by the psychiatrist

You may not qualify if:

  • Insomnia and depression before a stroke
  • Aphasic patients
  • Sleep Apnea Syndrome
  • Psychiatric Disorders (Learning disabilities, Mental disorder, Autism)
  • Decompensated cardiac, kidney, hepatic failure
  • Infection on Acupuncture Points
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (4)

  • Paolucci S. Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat. 2008 Feb;4(1):145-54. doi: 10.2147/ndt.s2017.

    PMID: 18728805BACKGROUND
  • Zhang ZJ, Chen HY, Yip KC, Ng R, Wong VT. The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis. J Affect Disord. 2010 Jul;124(1-2):9-21. doi: 10.1016/j.jad.2009.07.005. Epub 2009 Jul 26.

    PMID: 19632725BACKGROUND
  • Li M, Zhang B, Meng Z, Sha T, Han Y, Zhao H, Zhang C. Effect of Tiaoshen Kaiqiao acupuncture in the treatment of ischemic post-stroke depression: a randomized controlled trial. J Tradit Chin Med. 2017 Apr;37(2):171-8. doi: 10.1016/s0254-6272(17)30041-9.

    PMID: 29960288BACKGROUND
  • Kalaoglu E, Kesiktas FN, Bucak OF, Atasoy M, Gunderci A. Effectiveness of acupuncture treatment in post-stroke depression and anxiety disorders: a prospective, randomized, controlled, single-blind study. Acupunct Med. 2024 Dec;42(6):319-325. doi: 10.1177/09645284241298294. Epub 2024 Nov 26.

MeSH Terms

Conditions

Anxiety DisordersStrokeDepression

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Mental DisordersCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Eser Kalaoğlu, MD

    Istanbul Physical Medicine Rehabilitation Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2020

First Posted

February 25, 2020

Study Start

August 1, 2019

Primary Completion

November 30, 2020

Study Completion

December 1, 2020

Last Updated

February 9, 2021

Record last verified: 2021-02

Locations